These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18381442)

  • 1. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.
    Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P
    Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.
    Clarke ML; Damaraju VL; Zhang J; Mowles D; Tackaberry T; Lang T; Smith KM; Young JD; Tomkinson B; Cass CE
    Mol Pharmacol; 2006 Jul; 70(1):303-10. PubMed ID: 16617163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C-resistant CCRF-CEM-derived cells.
    Takagaki K; Katsuma S; Kaminishi Y; Horio T; Nakagawa S; Tanaka T; Ohgi T; Yano J
    J Biochem; 2004 Nov; 136(5):733-40. PubMed ID: 15632314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells.
    Sarkar M; Han T; Damaraju V; Carpenter P; Cass CE; Agarwal RP
    Biochem Pharmacol; 2005 Aug; 70(3):426-32. PubMed ID: 15950950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines.
    Kees UR; Ford J; Dawson VM; Piall E; Aherne GW
    Cancer Res; 1989 Jun; 49(11):3015-9. PubMed ID: 2720661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cytarabine-resistant leukemic cell lines established from five different blood cell lineages using gene expression and proteomic analyses.
    Negoro E; Yamauchi T; Urasaki Y; Nishi R; Hori H; Ueda T
    Int J Oncol; 2011 Apr; 38(4):911-9. PubMed ID: 21290089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells.
    Ohta T; Hori H; Ogawa M; Miyahara M; Kawasaki H; Taniguchi N; Komada Y
    Oncol Rep; 2004 Nov; 12(5):1115-20. PubMed ID: 15492802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1 expression.
    Jin G; Matsushita H; Asai S; Tsukamoto H; Ono R; Nosaka T; Yahata T; Takahashi S; Miyachi H
    Biochem Biophys Res Commun; 2009 Dec; 390(3):1001-6. PubMed ID: 19853583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High D-glucose reduces SLC29A1 promoter activity and adenosine transport involving specific protein 1 in human umbilical vein endothelium.
    Puebla C; Farías M; González M; Vecchiola A; Aguayo C; Krause B; Pastor-Anglada M; Casanello P; Sobrevia L
    J Cell Physiol; 2008 Jun; 215(3):645-56. PubMed ID: 18064606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
    Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
    J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells.
    Hummel-Eisenbeiss J; Hascher A; Hals PA; Sandvold ML; Müller-Tidow C; Lyko F; Rius M
    Mol Pharmacol; 2013 Sep; 84(3):438-50. PubMed ID: 23814180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytarabine-resistant leukemia cells are moderately sensitive to clofarabine in vitro.
    Yamauchi T; Uzui K; Nishi R; Shigemi H; Ueda T
    Anticancer Res; 2014 Apr; 34(4):1657-62. PubMed ID: 24692694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms underlying the enhanced sensitivity of thiopurine-resistant T-lymphoblastic cell lines to methyl mercaptopurineriboside.
    Fotoohi AK; Wrabel A; Moshfegh A; Peterson C; Albertioni F
    Biochem Pharmacol; 2006 Sep; 72(7):816-23. PubMed ID: 16859645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content.
    Wright AM; Paterson AR; Sowa B; Akabutu JJ; Grundy PE; Gati WP
    Br J Haematol; 2002 Mar; 116(3):528-37. PubMed ID: 11849208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of fluoropyrimidine-resistant murine leukemic cell lines by one-step mutation and selection.
    Mulkins MA; Heidelberger C
    Cancer Res; 1982 Mar; 42(3):956-64. PubMed ID: 6460554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.
    Gourdeau H; Clarke ML; Ouellet F; Mowles D; Selner M; Richard A; Lee N; Mackey JR; Young JD; Jolivet J; Lafrenière RG; Cass CE
    Cancer Res; 2001 Oct; 61(19):7217-24. PubMed ID: 11585758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
    Hapke DM; Stegmann AP; Mitchell BS
    Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.